Literature DB >> 2835683

The N-terminal region of the chicken progesterone receptor specifies target gene activation.

L Tora1, H Gronemeyer, B Turcotte, M P Gaub, P Chambon.   

Abstract

Steroid hormone receptors belong to a family of nuclear receptors that trigger transcriptional activation of target genes by specific binding to DNA recognition sequences, usually located in the 5'-flanking region of the target gene. Nuclear receptors appear to be segmented proteins and extensive structure-function analyses have attempted to elucidate the functional significance of individual segments. Two of these regions have been defined as the domains responsible for recognition of responsive elements of target genes (region C) and hormone binding (region E) (refs 2-7). But the functional significance of the N-terminal region (A/B), which diverges extensively even for a given receptor between different species, has remained obscure. We have previously cloned, expressed and analysed the chicken progesterone receptor (cPR) (ref. 8). This receptor and its human homologue from T47D breast cancer cells are unique among the steroid hormone receptors in that two forms, A and B, are present in equal amounts in cytosolic extracts, the latter having the higher molecular weight. For the chicken progesterone receptor, we have presented evidence suggesting that the cPR form A corresponds to an N-terminally truncated form of B (ref. 8). Here we report on the functional difference between the forms A and B in the transcriptional activation of two target genes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835683     DOI: 10.1038/333185a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  67 in total

Review 1.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

Review 2.  Progesterone receptors in mammary gland development and tumorigenesis.

Authors:  Orla M Conneely; Biserka M Jericevic; John P Lydon
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

Review 3.  Progesterone regulation of reproductive function through functionally distinct progesterone receptor isoforms.

Authors:  Orla M Conneely; Biserka M Jericevic
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

4.  Differential modes of activation define orphan subclasses within the steroid/thyroid receptor superfamily.

Authors:  J P Lydon; R F Power; O M Conneely
Journal:  Gene Expr       Date:  1992

5.  Heterotetrameric structure of the human progesterone receptor.

Authors:  P Rehberger; M Rexin; U Gehring
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

Review 6.  Nuclear thyroid hormone receptors.

Authors:  M A Lazar; W W Chin
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

Review 7.  Progesterone receptors, their isoforms and progesterone regulated transcription.

Authors:  Britta M Jacobsen; Kathryn B Horwitz
Journal:  Mol Cell Endocrinol       Date:  2011-09-17       Impact factor: 4.102

8.  Retinoic acid repression of bone morphogenetic protein 4 in inner ear development.

Authors:  Deborah L Thompson; Lisa M Gerlach-Bank; Kate F Barald; Ronald J Koenig
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

9.  The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells.

Authors:  D X Wen; Y F Xu; D E Mais; M E Goldman; D P McDonnell
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

10.  Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor alpha locus.

Authors:  M Alcalay; D Zangrilli; P P Pandolfi; L Longo; A Mencarelli; A Giacomucci; M Rocchi; A Biondi; A Rambaldi; F Lo Coco
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.